ACD

Boulder City, Colorado, United States
Boulder City, Colorado, United States
SEARCH FILTERS
Time filter
Source Type

News Article | May 19, 2017
Site: www.24-7pressrelease.com

AURORA, IL, May 19, 2017-- Richard Durante, Sr., founder of Tie National, LLC (http://www.tienational.com), a nationwide premier partner of quality and cost efficient IT solutions, has announced his retirement as President. Having held the title since 2003, Richard revealed that the position now belongs to his long time business partner, Michael R. Durante with whom he built Tie National, LLC from the ground up, and proudly calls his son."This has been, and always will be a family business. Each employee here is a part of the Tie National family. Our clients feel the pride we have in our business and the quality we provide as a team."- Richard Durante, Sr., former President of Tie National, LLC.Since the early 1970's, Richard has been involved with telecommunications. At Tie/communications, he moved up the ranks from a Director of Technical Services, to Regional Vice President of Sales and later as the Vice President of National Accounts. When Convergent Communications acquired Tie/communications in 1998, Richard continued to grow his telecom and technology as the Vice President of National Accounts at Convergent Communications.After the 2001 sale of Convergent Communications' telecom division to Intertel, Richard joined Cintech Solutions, a software company specializing in ACD systems, as Vice President of Sales. In 2003, Richard saw an opportunity to breathe new life into the trusted "Tie" name by creating his own business venture, Tie National Accounts, later changed to Tie National, LLC. He reached out to his previous Tie/Communications contacts, many of which had gone into business for themselves as local repair technicians and installers to be the starting foundation of a subcontractor base that now includes over 5,000 field resources across North America.Tie National, LLC's new President, Michael R. Durante began his professional career in banking. His aptitude for maintaining relationships with current clients and bringing in new customer business launched him from Senior Personal Banker at MidAmerica Bank in 1997 to the title of Senior Branch Manager at TCF Bank; a title he held until 2004. Despite his growing career in the financial industry, Michael joined Richard full time to help grow Tie National from a telecommunications company to the full technology integrator the business is today."We want to be the client's first call for anything IT related, even if just to ask about how a new technology might benefit their business. That level of partnership is critical for the ongoing success of our business."- Michael R. Durante, new President of Tie National, LLC.For thirteen years, Michael has been responsible for staying involved with information technology trends, understanding the benefits they bring to the business world, and actively training his engineers on the installation and maintenance for the technologies deployed. He has been a major voice in new products and services offered to enterprise and small business clients. Michael's authority over all procedures and operations while building the business served well in preparing for his recent promotion to President of Tie National, LLC.Michael looks forward to one day passing the torch onto his own children who are both currently under the age of three, "there is so much to learn every day in this industry. Because our services and products are so flexible and intentionally updated to reflect trending IT solutions, I look forward to the day when my kids are ready to learn from me the way I learned from their grandfather."Tie National, LLC provides flexible end-to-end IT consultation and solutions to businesses of all sizes. Expertise includes national dispatch coordination, remote IT support, hardware/software, managed services, and as-a-service solutions. Since 2003, Tie National has helped businesses make smart and cost-effective choices for their evolving technology needs and relieve exposed vulnerabilities.Contact:Kathy Powell630-518-9622


OTTAWA, May 01, 2017 (GLOBE NEWSWIRE) -- Aujourd’hui, c’est le Lundi du mélanome et l’Association canadienne de dermatologie (ACD) retourne sur la Colline pour offrir aux députés et aux sénateurs sa séance annuelle de dépistage du cancer de la peau. La séance de dépistage sur la colline du Parlement est coparrainée par Geoff Regan, président de la Chambre des communes, et Bill Casey, député de Cumberland-Colchester, et organisée par l’ACD. Il y a quelques années, M. Casey avait reçu un diagnostic de mélanome à l’occasion d’une séance de dépistage tenue sur la colline du Parlement, ce qui lui avait permis de recevoir rapidement un traitement et de combattre la maladie avec succès. L’événement en question avait été parrainé par Mme Dona Cadman, veuve du député Chuck Cadman, décédé d’un mélanome. Outre la détection précoce de cas de cancer, la séance de dépistage vise à sensibiliser les parlementaires aux signes du cancer de la peau et à leur faire connaître les mesures de prévention, qui sont toutes simples. Le dépistage et le traitement précoces du mélanome, du cancer basocellulaire et du cancer spinocellulaire permettent de réduire la gravité des cicatrices résultant du traitement et même, dans le cas du mélanome, de prévenir le décès. Pour réduire encore davantage les risques de cancer de la peau, il faut aussi éviter les pratiques dangereuses comme le bronzage artificiel. L’incidence du mélanome est à la hausse, tant chez les hommes que chez les femmes, depuis quelques décennies, le taux d’augmentation ayant atteint 2,4 % par année chez les hommes entre 2001 et 2010, et 2,8 % par année chez les femmes entre 2004 et 2010. L’exposition aux rayons ultraviolets (UV) du soleil, des lits de bronzage et des lampes solaires semble être le principal facteur de risque de mélanome. Le nombre et le type de grains de beauté, la peau claire, les antécédents familiaux de cancer de la peau, un système immunitaire affaibli et une histoire de coups de soleil graves avec cloques, sont parmi les autres facteurs de risque. Au sujet de l’ACD L’Association canadienne de dermatologie, fondée en 1925, représente les dermatologues du Canada. L’Association offre un accès facile à la source la plus importante et la plus fiable de savoir médical en dermatologie. L’ACD a pour mission de faire avancer la science et l’art de la médecine et de la chirurgie dans le domaine des soins de la peau, des cheveux et des ongles, d’offrir du perfectionnement professionnel continu à ses membres, d’appuyer et d’améliorer les soins aux patients, de sensibiliser le public à la protection solaire et aux autres aspects de la santé de la peau et de promouvoir la santé de la peau, des cheveux et des ongles, la vie durant. Ce faisant, l’ACD informe et habilite aussi bien les professionnels de la médecine que le public canadien.


OTTAWA, May 01, 2017 (GLOBE NEWSWIRE) -- Des membres du Conseil d’administration de l’ACD et des dermatologues et résidents en dermatologie de la région d’Ottawa offriront une séance de dépistage du cancer de la peau aux députés et sénateurs et leur apprendront comment on peut effectuer soi-même un examen de la peau à la maison. L’événement est organisé dans le cadre du Programme de prudence au soleil de l’Association canadienne de dermatologie.


News Article | May 2, 2017
Site: www.prnewswire.com

The company's financial statements are prepared in accordance with accounting principles generally accepted in the United States (GAAP). Adjusted EPS, adjusted earnings, adjusted gross margin, adjusted operating income, and adjusted operating margin are non-GAAP measures that exclude certain items detailed later in this press release under the heading "Use of Adjusted Financial Measures." A reconciliation of GAAP to non-GAAP financial measures is included in this press release. "My compliments to our global teams for a solid quarter with organic growth in the mid-single digits, led by Europe with organic growth in the upper-teens, a record for us," said Chuck Kummeth, President and Chief Executive Officer of Bio-Techne.  "We have many highlights to discuss this quarter including a return to growth in Japan and strong 20% growth in Protein Platforms.  ACD also continues to surprise us, with growth nearing 60%, well on its way to surpassing the milestones we gave the team for the final earn-out payment this December." Kummeth added, "However, timing of orders in our Diagnostics segment is still impacting overall Company quarterly growth rates. No business has been lost in this division, but an emphasis on inventory metrics by its large Dx customer base has pushed out some deliveries into next fiscal year. Longer term, the pipeline of new business for this division looks stronger than ever." Kummeth concluded, "With the ongoing integration of the nine acquisitions we have done over the past 3.5 years, our focus has been on maintaining high margins along with revenue growth.   With our latest acquisition, ACD, now absorbed into Bio-Techne's operating processes, our adjusted operating margins continue to improve.   True to our word, our adjusted operating margins in Q3 increased sequentially by over 200 basis points from Q2.  My thanks to our employees worldwide, now totaling near 1800, for the wonderful execution." Net sales for the third quarter increased 10% to $144.0 million. Organic growth was 4% compared to the prior year, with currency translation having a negative impact of 2% and acquisitions contributing 8% to revenue growth. GAAP EPS decreased to $0.57 per diluted share, versus $0.81 in the same quarter last year. GAAP operating income for the third quarter of fiscal 2017 decreased 26% to $32.3 million, compared with $43.5 million in the third quarter of fiscal 2016.  GAAP operating margin was 22.4%, compared with 33.2% in the third quarter of fiscal 2016. GAAP operating margin compared to prior year was negatively impacted by additional expenses associated with the acquisitions made in fiscal 2017. These expenses include selling, general and administrative expenses, acquisition intangible amortization, contingent consideration fair value adjustments, and other acquisition costs. GAAP diluted EPS was also negatively impacted by higher interest costs associated with the financing of recent acquisitions. Adjusted EPS decreased to $0.97 per diluted share, versus $1.01 in the same quarter last year. Adjusted operating income for the third quarter of fiscal 2017 decreased 3% compared to the same quarter last year. Adjusted operating margin was 37.3%, compared with 42.4% in the third quarter of fiscal 2016. Adjusted operating margin compared to prior year was negatively impacted by the mix of lower-margin acquisitions made in fiscal 2017. Adjusted EPS was negatively impacted by higher interest costs associated with the financing of recent acquisitions and benefitted from a lower adjusted effective income tax rate due to geographic mix. Management uses adjusted operating results to monitor and evaluate performance of the Company's three business segments, as highlighted below.  Since these results are used for this purpose, they are also considered to be prepared in accordance with GAAP. The Company's Biotechnology segment includes proteins, antibodies, immunoassays, flow cytometry products, intracellular signaling products, and biologically active chemical compounds used in biological research. Biotechnology segment's third quarter fiscal 2017 net sales were $94.5 million, an increase of 16% from $81.4 million for the third quarter of fiscal 2016. Organic growth for the segment was 6%, with currency translation having an unfavorable impact of 2% on revenue growth and acquisitions contributing 12% to revenue growth. Biotechnology segment adjusted operating margin was 47.9% in the third quarter of fiscal 2017 compared to 55.5% in the third quarter of fiscal 2016. The lower operating margin is largely the result of recent acquisitions, namely ACD, made in this segment. The Company's Protein Platforms segment develops proprietary systems and consumables for protein analysis. In the third quarter of fiscal 2017, segment revenue was $23.6 million, an increase of 20% from $19.7 million for the third quarter of fiscal 2016.  Organic growth for the segment was 20% with currency translation having an unfavorable impact of 2% and acquisitions contributing 1%. The Protein Platforms segment's adjusted operating margin was 13.8% in the third quarter of fiscal 2017 compared to 8.1% in the third quarter of fiscal 2016. The higher segment operating margin was primarily the result of volume leverage. The Company's Diagnostics segment provides a range of controls and calibrators for various blood and blood chemistry clinical instruments, as well as quality controls, diagnostic immunoassays and other bulk and custom reagents for the in vitro diagnostic market. The Diagnostics segment's third quarter fiscal 2017 net sales were $26.0 million, a decrease of 13% (all organic) compared to the third quarter of fiscal 2016. The Diagnostics segment's adjusted operating margin was 23.1% in the third quarter of fiscal 2017 compared to 31.6% in the third quarter of fiscal 2016. The lower operating margins were driven by a lower volume leverage and margin mix of product sales. Bio-Techne will host an earnings conference call today, May 2, 2017 at 8:00 A.M. Central time. To listen, please dial (877) 879-6203 or (719) 325-4749 for international callers. A recorded rebroadcast will be available for interested parties unable to participate in the live conference call. The replay will be available from 11:00 P.M. Central time on Tuesday, May 2, until 5:00 P.M. Central time on Friday, June 2, 2017. To access the replay please go to: http://audio.viavid.com/20170502-123977-bio-techne.mp3 Use of Adjusted Financial Measures: This press release contains financial measures that have not been calculated in accordance with accounting principles generally accepted in the U.S. (GAAP). These non-GAAP measures include: We provide these measures as additional information regarding our operating results. We use these non-GAAP measures internally to evaluate our performance and in making financial and operational decisions, including with respect to incentive compensation. We believe that our presentation of these measures provides investors with greater transparency with respect to our results of operations and that these measures are useful for period-to-period comparison of results. Our non-GAAP financial measures for adjusted gross margin, adjusted operating margin, and adjusted net earnings, in total and on a per share basis, exclude the costs recognized upon the sale of acquired inventory, amortization of acquisition intangibles, and acquisition related expenses.  The Company excludes amortization of purchased intangible assets and purchase accounting adjustments, including costs recognized upon the sale of acquired inventory and acquisition-related expenses, from this measure because they occur as a result of specific events, and are not reflective of our internal investments, the costs of developing, producing, supporting and selling our products, and the other ongoing costs to support our operating structure.   Additionally, these amounts can vary significantly from period to period based on current activity. The Company's non-GAAP adjusted operating margin and adjusted net earnings, in total and on a per share basis, also excludes stock based compensation expense and certain adjustments to income tax expense.  Stock based compensation is excluded from non-GAAP adjusted earnings because of the nature of this charge, specifically the varying available valuation methodologies, subjective assumptions, and the variety of award types.  The Company independently calculates a non-GAAP adjusted tax rate to be applied to the identified non-GAAP adjustments considering the impact of discrete items on these adjustments and the jurisdictional mix of the adjustments.  In addition, the tax impact of other discrete and non-recurring charges which impact our reported GAAP tax rate are adjusted from net earnings.  We believe these tax items can significantly affect the period-over period assessment of operating results and not necessarily reflect costs and/or income associated with historical trends and future results. Investors are encouraged to review the reconciliations of adjusted financial measures used in this press release to their most directly comparable GAAP financial measures as provided with the financial statements attached to this press release. Our press releases may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act. Such statements involve risks and uncertainties that may affect the actual results of operations. The following important factors, among others, have affected and, in the future, could affect the Company's actual results: the effect of new branding and marketing initiatives, the integration of new leadership, the introduction and acceptance of new products, the funding and focus of the types of research by the Company's customers, the impact of the growing number of producers of biotechnology research products and related price competition, general economic conditions, the impact of currency exchange rate fluctuations, and the costs and results of research and product development efforts of the Company and of companies in which the Company has invested or with which it has formed strategic relationships. For additional information concerning such factors, see the section titled "Risk Factors" in the Company's annual report on Form 10-K and quarterly reports on Form 10-Q as filed with the Securities and Exchange Commission. We undertake no obligation to update or revise any forward-looking statements we make in our press releases due to new information or future events. Investors are cautioned not to place undue emphasis on these statements. Bio-Techne Corporation (NASDAQ: TECH) is a leading developer and manufacturer of high quality purified proteins––notably cytokines and growth factors, antibodies, immunoassays, as well as biologically active small molecule compounds --- which are sold to biomedical researchers and clinical research laboratories; these operations constitute the core Biotechnology Division, headquartered in Minneapolis, Minnesota. The Protein Platforms Division manufactures innovative protein analysis tools under the ProteinSimple brand name that greatly automate western blotting and immunoassay practices. The Diagnostics Division manufactures FDA-regulated controls, calibrators, blood gas and clinical chemistry controls and other reagents for OEM customer and clinical customers. Bio-Techne products are integral components of scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With thousands of products in its portfolio, Bio-Techne generated approximately $499 million in net sales in fiscal 2016 and has approximately 1,700 employees worldwide. For more information on Bio-Techne and its brands, please visit www.bio-techne.com. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/bio-techne-releases-third-quarter-fiscal-2017-results-300449194.html


This is Detroit's largest single announcement of new apartment units, affordable units and redeveloped historic buildings in more than 20 years. American Community Developers, Inc. (ACD), a local developer with significant affordable housing experience, will team with Olympia Development on five high-profile properties near Little Caesars Arena. The highly-experienced, Detroit-based team at Bagley Development Group will partner with Olympia Development to redevelop the majestic 18-story structure at 150 Bagley, just west of Grand Circus Park. "Olympia Development's plan to preserve several historic buildings and bring hundreds of new residential units into the heart of the city is a clear sign of the demand for housing in Detroit," said Detroit Mayor Mike Duggan. "The fact that they are including nearly 140 units of new affordable housing across these six developments aligns perfectly with our efforts to build a city that includes everyone." "The District Detroit will be one of the most exciting places in the country to live," said Christopher Ilitch, president and CEO of Ilitch Holdings, Inc. "These six uniquely Detroit residential developments will be in the heart of the action, in a city on the rise." The District Detroit, a 50-block, mixed-use development led by the Ilitch organization, is a world-class sports and entertainment destination built around eight theaters, all four major sports teams, three professional sports venues and new restaurants, shops, offices and places to live – connecting Downtown to Midtown Detroit into one vibrant area. "I am very optimistic about the opportunity for a dynamic development at 150 Bagley," said Emmett Moten, Jr., Team Executive for Bagley Development Group and a veteran Detroit developer. "This well-known building has a high-demand location, and we believe its renovation will be well received by the entire community." "We're excited to be part of such a transformational development in our hometown," said Jerry Krueger, president of American Community Developers, Inc. "We're proud to play a role in the renovation of three historic buildings as well as the development of new landmark properties in The District Detroit." The new residential developments in The District Detroit will offer a variety of great amenities including historic building living, in-unit laundry, high ceilings, plenty of windows, keyless entry, a tenant notification system and 24-hour package service – all in an exciting mix of vibrant shops, restaurants and bars and great proximity to the new QLINE street car: Bagley Development Group, led by an African American ownership team, has a unique understanding of affordable and market-rate housing and a strategic team with a strong local presence that supports The District Detroit mission. The primary principals have several decades of experience in real estate development, management, design and construction. ACD has been an active developer in the City of Detroit for over 20 years and currently has more than 2,200 apartments in the city. Recent developments include Crystal Lofts in Midtown, the historic Himelhoch building and Washington Boulevard Apartments downtown, Oakman Townhomes in Hope Village and Central Towers in southwest Detroit. Crystal Lofts is a mixed-use building located on Woodward Avenue in Midtown and is home to the Grey Ghost restaurant and the future home of New Order Coffee Roasters as well as the Mexican-themed Bakersfield restaurant. Oakman Townhomes is currently under construction and contains 72 affordable townhomes. Central Towers is currently under renovation and contains 232 affordable apartments. To indicate your interest in residential developments in The District Detroit visit www.DistrictDetroit.com/Residential and follow us on Instagram, Facebook and Twitter. The District Detroit is one of the largest sports and entertainment developments in the country. Located in the heart of Detroit, this 50-block, mixed-use development led by the Ilitch organization unites eight world-class theaters, five neighborhoods and three professional sports venues in one vibrant, walkable destination for people who want to live, work and play in an exciting urban environment. Home to the Detroit Tigers, Detroit Red Wings, Detroit Pistons and Detroit Lions – The District Detroit represents the greatest density of professional sports teams in one downtown core in the country. Data from the University of Michigan demonstrates that The District Detroit will ultimately account for an economic impact of more than $2 billion by 2020 and create 12,500 construction and construction-related jobs and 1,100 permanent jobs. More than $100 million in income from the Little Caesars Arena alone is expected for Detroit residents, with significant additional income to be created through future private development. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/the-district-detroit-announces-detroits-largest-residential-development-initiative-in-more-than-20-years-300464634.html


News Article | May 23, 2017
Site: www.prweb.com

Noble Systems Corporation, a global leader in omnichannel contact center technology solutions, introduces Noble® Secure Payment Assist, a new tool for safeguarding sensitive customer data while improving the customer experience. Securing credit card and payment information is critical, and improving data security for consumers is a leading initiative throughout the industry. Noble Secure Payment Assist utilizes Noble's patented technologies for agent-assisted transactions to help you manage payments in a protected environment. Using automated tools with touch-tone and data masking, organizations can eliminate PCI scope, reduce the risk of fraud and theft, lower costs, improve agent workflows, and create a better customer experience. Chris Hodges, Noble’s Senior VP Sales and Marketing, said, “While data security is mandatory for PCI Compliance, it’s also an integral part of the customer experience. Consumers want to have the peace of mind that the companies they do business with are safeguarding their sensitive data. Secure Payment Assist allows contact centers to manage customer payments for collections, sales, and services safely and efficiently, while providing the convenience of having an agent on the line to provide assistance if needed.” With Secure Payment Assist, agents stay engaged with the customer during and after the payment transaction, but the credit card data is never exposed. Agents do not hear or see the data, it is not stored in the system nor captured in the audio or video recording. Secure Payment Assist is available as part of Noble’s premise and cloud-based solutions. About Noble Systems Noble Systems Corporation is a global leader in the customer communications industry, providing innovative solutions for Contact Center, Workforce Management, and Analytics technologies. Tens of thousands of agents at 4,000+ client installations worldwide use Noble platforms to manage millions of customer contacts each day. Noble offers a unified suite of inbound, outbound and blended omnichannel communications, strategy planning, and resource management tools for companies of all sizes. Our premise, cloud, and innovative premise/cloud hybrid platforms include ACD, predictive dialing, blended processing, recording and monitoring, IVR, messaging, interaction analytics, decisioning, and workforce management. For more information, contact Lee Allum at 1.888.8NOBLE8 or visit http://www.noblesystems.com.


"Having your Cloud ACD with a side of WFO is a waste of both resources," states Kegel. "I look forward to sharing how an organization cannot fully realize the benefits of each component unless they work together and not operate in parallel lines." As a Platinum Sponsor for the conference, eLoyalty will be showcasing its Cloud and Workforce Optimization offerings at Booth #3 during the conference. With features including email, chat, icPortal®/icPortal Mobile, IVR, CRM integrations, 24x7x365 support, high availability, and disaster recovery, the scalable eLoyalty Experience and Experience+ solutions allow mid-sized businesses to provide the superior customer experience once available only to the largest enterprise organizations. Other product highlights include eLoyalty's powerful Workforce Optimization (WFO) solution for both mid-sized and enterprise organizations. Delivering the industry's most robust WFO platform, eLoyalty's Cloud with Verint WFO provides unmatched functionality, simplified system administration and maintenance, real-time enterprise collaboration, and intuitive interfaces and navigation. Together, eLoyalty's global experience in Contact Center as a Service (CCaaS) and existing cloud infrastructure combined with Verint's top-of-the-line WFO suite provide a best-of-breed solution at a compelling price point. For more information on eLoyalty's Cloud solutions for mid-size to enterprise organizations, please visit www.eloyalty.com, ABOUT TELETECH TeleTech (NASDAQ: TTEC) is a leading global provider of customer experience, engagement and growth solutions delivered through a proprietary end-to-end Customer Engagement as a Service offering. Founded in 1982, the Company helps its clients acquire, retain and grow profitable customer relationships. Using customer-centric strategy, technology, processes and operations, TeleTech partners with business leadership across marketing, sales and customer care to design and deliver a simple, more human customer experience across every interaction channel. TeleTech's 48,000 employees live by a set of customer-focused values that guide relationships with clients, their customers, and each other. To learn more about how TeleTech is bringing humanity to the customer experience, visit TeleTech.com. ABOUT ELOYALTY eLoyalty, a TeleTech (NASDAQ: TTEC) company, was the first North American partner to achieve Cisco HCS Certification and Contact Center as a Service Designation, has received the Cisco Advanced Technology Partner Certification for Contact Center Enterprise and Customer Voice Portal, and the Cisco Customer Satisfaction Award every year since 2007. We are the only Cisco Cloud Partner offering a solution with this type of increased flexibility and capability incorporated directly into the HCS platform. With a 95 percent client renewal rate, eLoyalty has proven itself a deserving partner as it helps chart customer experience technology roadmaps, implementing cloud systems to provide safer, faster, smarter, and more agile service interactions. For more information, visit eLoyalty.com. Verint is a registered trademark of Verint, Inc. icPortal is a trademark of eLoyalty, a TeleTech Company. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/eloyalty-a-teletech-company-to-present-best-in-class-cloud-and-workforce-optimization-solutions-at-engage-2017-300461883.html


News Article | August 16, 2017
Site: www.prweb.com

As the electronics industry continuously evolves at a fast pace, ACDi recognizes the importance of recruiting new talent with fresh ideas. With that approach, ACDi announces the hiring of Priya Sherke as our newest printed circuit board design engineer. Ms. Sherke has spent the past five years with progressive growth at Sanstar Microsystems in Nagpur, India where she was responsible for PCB design, switching mode power supply design, security systems design and technical support for process and field instruments. She is also skilled in testing, and analysis of SMPS, as well as project co-ordination. She holds a Bachelor’s degree in Electronics and Telecommunications from Nagpur University and earned a diploma in software testing from SEED Infotech. “I’m very excited to join ACDi,” said Ms. Sherke. “I feel like I can learn a lot from the team that has been designing for so long and look forward to adding value to the PCB layout services we offer.” About ACDi Based in Frederick, MD and Nashville, NC, ACDi is an integral resource to companies who need a trusted partner for dynamic electronics manufacturing, engineering and design expertise to successfully bring their electronic products to market. Our product engineering services, PCB layout, NPI, electronics manufacturing services, testing, systems integration and product lifecycle management solutions enable OEMs to focus on their business while we focus on product realization and optimization. ACDi clients gain a hands-on extension to their business as we turn their concepts into functional product. To learn more about ACDi visit our website here: http://www.acdi.com/


News Article | May 11, 2017
Site: www.prweb.com

Noble Systems Corporation, a global leader in unified contact center technology solutions, will be showcasing its industry-leading solutions for Contact Center, Workforce Management, and Analytics at ICMI’s 2017 Contact Center Expo, to be held May 22 - 25, 2017 in Orlando. The Contact Center Expo & Conference is the contact center industry’s most essential educational experience. Each year, ICMI produces a freshly conceived event designed to meet the needs of all contact center professionals. Through keynote presentations, networking events, local contact center tours, case studies and more, attendees gain practical tips that can be implemented immediately, along with tools and inspiration for success. Noble Systems’ solutions help companies manage the range of customer communications and related processes, including omnichannel inbound / outbound contact technologies, analytics and automated decisioning tools, and resource management, to help improve the customer experience. The Noble® Inbound 100 solution is designed specifically to target the needs of inbound service organizations and offers a 100% uptime guarantee. Noble Omnichannel Multi-session Agent maximizes service rep productivity with multi-session assignments, allowing them to handle voice and non-voice contacts concurrently. Our patented SmartAccept® technology helps increase speed of service, decrease average speed to answer, and reduce costs. Noble’s innovative premise, cloud and hybrid-based platforms allow organizations to increase efficiency, performance, and productivity throughout their contact center programs while decreasing overhead and maintaining compliance with legislative and industry guidelines. ICMI attendees can visit Noble Systems in booth 433. About Noble Systems Noble Systems Corporation is a global leader in the customer communications industry, providing innovative solutions for Contact Center, Workforce Management, and Analytics technologies. Tens of thousands of agents at 4,000+ client installations worldwide use Noble platforms to manage millions of customer contacts each day. Noble offers a unified suite of inbound, outbound and blended omnichannel communications, strategy planning, and resource management tools for companies of all sizes. Our premise, cloud, and innovative premise/cloud hybrid platforms include ACD, predictive dialing, blended processing, recording and monitoring, IVR, messaging, interaction analytics, decisioning, and workforce management. For more information, contact Lee Allum at 1.888.8NOBLE8 or visit http://www.noblesystems.com.


News Article | May 11, 2017
Site: www.winespectator.com

Multiple studies find that wine may lower risk, but scientists are just beginning to understand why A new analysis of medical research finds that a nightly glass of wine with your dinner could be helping protect your brain from the risk of developing dementia. But scientists have yet to agree on why. For several years, researchers have examined alcohol's potential effects on the risk of developing dementia—both positive and negative. Many recent studies have found that moderate alcohol consumption can have a protective effect, but due to different methodologies, theories and the sheer number of studies out there, deciphering what it all means can be a bit tricky. Hoping to bring focus to the debate, researchers from Qingdao Municipal Hospital and Ocean University, both in China, conducted a meta-analysis of recent research on the topic. They looked at 11 all-cause dementia (ACD) studies with 73,330 participants, five Alzheimer’s dementia studies with 52,715 participants and four vascular dementia studies with 49,535 participants. They used a random-effect model to analyze the data. The main conclusion of the study supports the idea that light to moderate alcohol consumption—one drink per day or less, according to this analysis—confers a lower risk of all-cause dementia than total abstinence. On the other hand, the researchers found that the risk for dementia was higher for those who consume more than three to four drinks per day, or 23 drinks per week. A closer look at the results shows more good news for wine lovers: Of the studies analyzed, seven addressed the type of alcohol consumed, and the analysis concluded that wine (consumed in light to moderate amounts) was the only alcoholic beverage that appeared to possess notable protective effects against dementia. Heavy beer drinkers appeared to suffer a higher risk of dementia. Why does wine protect the mind? The International Scientific Forum on Alcohol Research (ISFAR), a group of scientists and researchers dedicated to analyzing alcohol and health-related studies, published a critique of the meta-analysis. Members of ISFAR, including medical practitioners, university professors and public health specialists, discussed potential explanations for the findings. One familiar theory: the anti-inflammatory and antioxidant properties of polyphenols in wine could be a contributing factor. But members also suggested other mechanisms. Ethanol is believed to stimulate the release of acetylcholine in the brain, which leads to improved cognitive function. Another theory is that gallic acid, which the body produces when consuming red wine, can block the aggregation of beta amyloid in the brain. Those peptides are involved in the development of dementia. Overall, ISFAR members commended the meta-analysis for its vast sample size and methodology, but asserted that there is still much more research to be done to understand the complicated relationship between alcohol and dementia. So what does this mean for wine drinkers? "It's pretty clear that people who drink wine [are] lowering the risk of developing dementia; what we were trying to do is see why this is true," explained Dr. Curtis Ellison, codirector of ISFAR and professor at Boston University School of Medicine. "It’s the polyphenols in wine that seem to give it extra protection, and it's probably that polyphenols work best with alcohol. [But wine] also evidently has mechanisms that are still poorly understood." Ellison, who studied wine's health benefits with the "father of the French paradox" Serge Renaud, told Wine Spectator that the best way to reap wine's benefits is to drink moderately, with food, throughout the course of the week. "We're not saying to go out and drink to prevent dementia. However, if you decide that you're going to have wine with your meal every night, you can know that you're getting a side benefit."

Loading ACD collaborators
Loading ACD collaborators